CIKS/DDX3X interaction controls the stability of the Zc3h12a mRNA induced by IL-17

Journal of Immunology

Volumn 194, Issue 7, 2015, Pages 3286-3294

  Somma, Domenico ^a   Mastrovito, Paola ^a   Grieco, Marianeve ^a   Lavorgna, Alfonso ^a   Pignalosa, Angelica ^a   Formisano, Luigi ^a   Salzano, Anna Maria ^b   Scaloni, Andrea ^b   Pacifico, Francesco ^b   Siebenlist, Ulrich ^c   Leonardi, Antonio ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CELL PROTEIN; CONNECTION TO I KAPPA B AND STRESS ACTIVATED PROTEIN KINASE; DDX3X PROTEIN; HELICASE; I KAPPA B KINASE EPSILON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; MESSENGER RNA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 5; UNCLASSIFIED DRUG; DDX3X PROTEIN, HUMAN; DEAD BOX PROTEIN; I KAPPA B KINASE; MULTIPROTEIN COMPLEX; PROTEIN BINDING; RIBONUCLEASE; TRAF3IP2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR; ZC3H12A PROTEIN, HUMAN;

AMINO TERMINAL SEQUENCE; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME STRUCTURE; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; RNA STABILITY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM;

DEAD-BOX RNA HELICASES; GENE EXPRESSION REGULATION; HUMANS; I-KAPPA B KINASE; INTERLEUKIN-17; MULTIPROTEIN COMPLEXES; PROTEIN BINDING; RIBONUCLEASES; RNA STABILITY; RNA, MESSENGER; TNF RECEPTOR-ASSOCIATED FACTOR 2; TNF RECEPTOR-ASSOCIATED FACTOR 5; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PEPTIDES AND PROTEINS;

EID: 84925845759     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401589     Document Type: Article

References (43)

1. Korn, T., E. Bettelli, M. Oukka, and V. K. Kuchroo. 2009. IL-17 and Th17 cells. Annu. Rev. Immunol. 27: 485-517.
2. Gaffen, S. L. 2009. Structure and signalling in the IL-17 receptor family. Nat. Rev. Immunol. 9: 556-567.
3. Ziolkowska, M., A. Koc, G. Luszczykiewicz, K. Ksiezopolska-Pietrzak, E. Klimczak, H. Chwalinska-Sadowska, and W. Maslinski. 2000. High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J. Immunol. 164: 2832-2838.
4. Pisitkun, P., H. L. Ha, H. Wang, E. Claudio, C. C. Tivy, H. Zhou, T. N. Mayadas, G. G. Illei, and U. Siebenlist. 2012. Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis. Immunity 37: 1104-1115.
5. Kolls, J. K. 2010. Th17 cells in mucosal immunity and tissue inflammation. Semin. Immunopathol. 32: 1-2.
6. Miossec, P., and J. K. Kolls. 2012. Targeting IL-17 and TH17 cells in chronic inflammation. Nat. Rev. Drug Discov. 11: 763-776.
7. Chang, S. H., and C. Dong. 2011. Signaling of interleukin-17 family cytokines in immunity and inflammation. Cell. Signal. 23: 1069-1075.
8. Leonardi, A., A. Chariot, E. Claudio, K. Cunningham, and U. Siebenlist. 2000. CIKS, a connection to IκB kinase and stress-activated protein kinase. Proc. Natl. Acad. Sci. USA 97: 10494-10499.
9. Li, X., M. Commane, H. Nie, X. Hua, M. Chatterjee-Kishore, D. Wald, M. Haag, and G. R. Stark. 2000. Act1, an NF-κB-activating protein. Proc. Natl. Acad. Sci. USA 97: 10489-10493.
10. Chang, S. H., H. Park, and C. Dong. 2006. Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor. J. Biol. Chem. 281: 35603-35607.
11. Qian, Y., C. Liu, J. Hartupee, C. Z. Altuntas, M. F. Gulen, D. Jane-Wit, J. Xiao, Y. Lu, N. Giltiay, J. Liu, et al. 2007. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat. Immunol. 8: 247-256.
12. Sønder, S. U., S. Saret, W. Tang, D. E. Sturdevant, S. F. Porcella, and U. Siebenlist. 2011. IL-17-induced NF-κB activation via CIKS/Act1: physiologic significance and signaling mechanisms. J. Biol. Chem. 286: 12881-12890.
13. Sun, D., M. Novotny, K. Bulek, C. Liu, X. Li, and T. Hamilton. 2011. Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF). Nat. Immunol. 12: 853-860.
14. Bulek, K., C. Liu, S. Swaidani, L. Wang, R. C. Page, M. F. Gulen, T. Herjan, A. Abbadi, W. Qian, D. Sun, et al. 2011. The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation. Nat. Immunol. 12: 844-852.
15. Hartupee, J., C. Liu, M. Novotny, X. Li, and T. Hamilton. 2007. IL-17 enhances chemokine gene expression through mRNA stabilization. J. Immunol. 179: 4135-4141.
16. Garneau, N. L., J. Wilusz, and C. J. Wilusz. 2007. The highways and byways of mRNA decay. Nat. Rev. Mol. Cell Biol. 8: 113-126.
17. Jankowsky, E. 2011. RNA helicases at work: binding and rearranging. Trends Biochem. Sci. 36: 19-29.
18. Linder, P., and F. V. Fuller-Pace. 2013. Looking back on the birth of DEAD-box RNA helicases. Biochim. Biophys. Acta 1829: 750-755.
19. Linder, P., and E. Jankowsky. 2011. From unwinding to clamping: the DEAD box RNA helicase family. Nat. Rev. Mol. Cell Biol. 12: 505-516.
20. Schröder, M. 2010. Human DEAD-box protein 3 has multiple functions in gene regulation and cell cycle control and is a prime target for viral manipulation. Biochem. Pharmacol. 79: 297-306.
21. Sun, M., L. Song, Y. Li, T. Zhou, and R. S. Jope. 2008. Identification of an antiapoptotic protein complex at death receptors. Cell Death Differ. 15: 1887-1900.
22. Chang, P. C., C. W. Chi, G. Y. Chau, F. Y. Li, Y. H. Tsai, J. C. Wu, and Y. H. Wu Lee. 2006. DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control. Oncogene 25: 1991-2003.
23. Botlagunta, M., F. Vesuna, Y. Mironchik, A. Raman, A. Lisok, P. Winnard, Jr., S. Mukadam, P. Van Diest, J. H. Chen, P. Farabaugh, et al. 2008. Oncogenic role of DDX3 in breast cancer biogenesis. Oncogene 27: 3912-3922.
24. waf1/cip1 promoter, is a candidate tumor suppressor. Cancer Res. 66: 6579-6588.
25. Oshiumi, H., K. Sakai, M. Matsumoto, and T. Seya. 2010. DEAD/H BOX 3 (DDX3) helicase binds the RIG-I adaptor IPS-1 to up-regulate IFN-β-inducing potential. Eur. J. Immunol. 40: 940-948.
26. Soulat, D., T. Bürckstümmer, S. Westermayer, A. Goncalves, A. Bauch, A. Stefanovic, O. Hantschel, K. L. Bennett, T. Decker, and G. Superti-Furga. 2008. The DEAD-box helicase DDX3X is a critical component of the TANKbinding kinase 1-dependent innate immune response. EMBO J. 27: 2135-2146.
27. Schröder, M., M. Baran, and A. G. Bowie. 2008. Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activation. EMBO J. 27: 2147-2157.
28. Jura, J., L. Skalniak, and A. Koj. 2012. Monocyte chemotactic protein-1-induced protein-1 (MCPIP1) is a novel multifunctional modulator of inflammatory reactions. Biochim. Biophys. Acta 1823: 1905-1913.
29. Matsushita, K., O. Takeuchi, D. M. Standley, Y. Kumagai, T. Kawagoe, T. Miyake, T. Satoh, H. Kato, T. Tsujimura, H. Nakamura, and S. Akira. 2009. Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay. Nature 458: 1185-1190.
30. Mizgalska, D., P. Wegrzyn, K. Murzyn, A. Kasza, A. Koj, J. Jura, B. Jarzab, and J. Jura. 2009. Interleukin-1-inducible MCPIP protein has structural and functional properties of RNase and participates in degradation of IL-1β mRNA. FEBS J. 276: 7386-7399.
31. Liang, J., Y. Saad, T. Lei, J. Wang, D. Qi, Q. Yang, P. E. Kolattukudy, and M. Fu. 2010. MCP-induced protein 1 deubiquitinates TRAF proteins and negatively regulates JNK and NF-κB signaling. J. Exp. Med. 207: 2959-2973.
32. Claudio, E., S. U. Sønder, S. Saret, G. Carvalho, T. R. Ramalingam, T. A. Wynn, A. Chariot, A. Garcia-Perganeda, A. Leonardi, A. Paun, et al. 2009. The adaptor protein CIKS/Act1 is essential for IL-25-mediated allergic airway inflammation. J. Immunol. 182: 1617-1630.
33. Mauro, C., P. Vito, S. Mellone, F. Pacifico, A. Chariot, S. Formisano, and A. Leonardi. 2003. Role of the adaptor protein CIKS in the activation of the IKK complex. Biochem. Biophys. Res. Commun. 309: 84-90.
34. Candiano, G., M. Bruschi, L. Musante, L. Santucci, G. M. Ghiggeri, B. Carnemolla, P. Orecchia, L. Zardi, and P. G. Righetti. 2004. Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis 25: 1327-1333.
35. D'Ambrosio, C., S. Arena, A. M. Salzano, G. Renzone, L. Ledda, and A. Scaloni. 2008. A proteomic characterization of water buffalo milk fractions describing PTM of major species and the identification of minor components involved in nutrient delivery and defense against pathogens. Proteomics 8: 3657-3666.
36. Scippa, G. S., M. Rocco, M. Ialicicco, D. Trupiano, V. Viscosi, M. Di Michele, S. Arena, D. Chiatante, and A. Scaloni. 2010. The proteome of lentil (Lens culinaris Medik.) seeds: discriminating between landraces. Electrophoresis 31: 497-506.
37. Tada, K., T. Okazaki, S. Sakon, T. Kobarai, K. Kurosawa, S. Yamaoka, H. Hashimoto, T. W. Mak, H. Yagita, K. Okumura, et al. 2001. Critical roles of TRAF2 and TRAF5 in tumor necrosis factor-induced NF-κB activation and protection from cell death. J. Biol. Chem. 276: 36530-36534.
38. Sønder, S. U., A. Paun, H. L. Ha, P. F. Johnson, and U. Siebenlist. 2012. CIKS/Act1-mediated signaling by IL-17 cytokines in context: implications for how a CIKS gene variant may predispose to psoriasis. J. Immunol. 188: 5906-5914.
39. Soto-Rifo, R., P. S. Rubilar, T. Limousin, S. de Breyne, D. Décimo, and T. Ohlmann. 2012. DEAD-box protein DDX3 associates with eIF4F to promote translation of selected mRNAs. EMBO J. 31: 3745-3756.
40. Iwasaki, H., O. Takeuchi, S. Teraguchi, K. Matsushita, T. Uehata, K. Kuniyoshi, T. Satoh, T. Saitoh, M. Matsushita, D. M. Standley, and S. Akira. 2011. The IκB kinase complex regulates the stability of cytokine-encoding mRNA induced by TLR-IL-1R by controlling degradation of regnase-1. Nat. Immunol. 12: 1167-1175.
41. Gu, L., A. Fullam, R. Brennan, and M. Schröder. 2013. Human DEAD box helicase 3 couples IκB kinase ε to interferon regulatory factor 3 activation. Mol. Cell. Biol. 33: 2004-2015.
42. Uehata, T., and S. Akira. 2013. mRNA degradation by the endoribonuclease Regnase-1/ZC3H12a/MCPIP-1. Biochim. Biophys. Acta 1829: 708-713.
43. + helper T cells regulates immune activation. Cell 153: 1036-1049.